Table 1.
Deflation/Rupture (MRI Cohort). FDA trial data for primary augmentation.
| Breast Implant | Time Frame | Kaplan-Meier Risk Rate of 1st Occurrence |
|---|---|---|
| IDEAL IMPLANT | 8 year | 2.1% |
| Allergan Gel | 8 year | 7.4% |
| Mentor Gel | 8 year | 13.6% |
| Sientra Gel | 8 year | 7.2% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.